^○Naoki Inui¹, Shunichi Sugawara², Toyoaki Hida³, Tatsuya Yoshida⁴, Hiroshi Tanaka⁵, Toru Kumagai⁶, Terufumi Kato⁷, Shunsuke Teraoka⁸, Isamu Okamoto⁹, Yukio Hosomi¹⁰, Tatsuro Fukuhara¹¹, Go Naka¹², Nobuhiko Seki¹³, Makoto Nishio¹⁴, Yuichiro Ohe⁴, Tomohide Tamura¹⁵, Nobuyuki Yamamoto⁸, Hiroaki Akamatsu⁸, Shigeru Takahashi¹⁶, Kazuhiko Nakagawa¹⁷ (1.Department of Pulmonary Medicine, Hamamatsu University Hospital, 2.Department of Pulmonary Medicine, Sendai Kousei Hospital, 3.Department of Thoracic Oncology, Aichi Cancer Center, 4.Department of Thoracic Oncology, National Cancer Center Hospital, 5.Department of Internal Medicine, Niigata Cancer Center Hospital, 6.Department of Thoracic Oncology, Osaka International Cancer Institute, 7.Department of Thoracic Oncology, Kanagawa Cancer Center, 8.Internal Medicine III, Wakayama Medical University, 9.Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, 10.Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 11.Department of Respiratory Medicine, Miyagi Cancer Center, 12.Department of Respiratory Medicine, National Center for Global Health and Medicine, 13.Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine, 14.Department of Thoracic Medical Oncology, Cancer Institute Hospital of JFCR, 15.Thoracic Center, St.Luke’s International Hospital, 16.Oncology Clinical Development Planning 1, Ono Pharmaceutical Co.,LTD., 17.Department of Medical Oncology, Kindai University Faculty of Medicine)

^○Haruhiro Saito¹, Melissa L Johnson², Byoung Chul Cho³, Alexander Luft⁴, Jorge A. Alatorre-Alexander⁵, Sarayut Lucien Geater⁶, Konstantin Laktionov⁷, Aleksandr Vasiliev⁸, Dmytro Trukhin⁹, Sang-We Kim¹⁰, Grygorii Ursol¹¹, Maen Hussein¹², Farah Louise Lim¹³, Cheng-Ta Yang¹⁴, Luiz Henrique Araujo¹⁵, Niels Reinmuth¹⁶, Xiaojin Shi¹⁷, Lynne Poole¹⁸, Solange Peters¹⁹, Edward B. Garon²⁰, Tony Mok²¹ (1.Kanagawa Cancer Center, Yokohama, Japan, 2.Sarah Cannon Research Institute, Tennessee Oncology, PLLCC, Nashville, TN, USA, 3.Yonsei Cancer Center, Seoul, Korea, 4.Leningrad Regional Clinical Hospital, St Petersburg, Russia, 5.Health Pharma Professional Research, Mexico City, Mexico, 6.Prince of Songkla University, Songkhla, Thailand, 7.Federal State Budgetary Institution “N.N. Blokhin National Medical Research Center of Oncology” of the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO), Moscow, Russia, 8.“Private Health Institution “Clinical Hospital” RZD-Medicine”, St Petersburg, Russia, 9.Odessa Regional Oncological Dispensary, Odessa, Ukraine, 10.Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, 11.Acinus, Kropyvnytskyi, Ukraine, 12.Florida Cancer Specialists – Sarah Cannon Research Institute, Leesburg, FL, USA, 13.Queen Mary University of London, London, United Kingdom, 14.Chang Gung Memorial Hospital, Taoyuan City, Taiwan, 15.Instituto Nacional de Cancer-INCA, Rio de Janeiro, Brazil, 16.Asklepios Lung Clinic, Munich-Gauting, Germany, 17.AstraZeneca, Gaithersburg, MD, USA, 18.AstraZeneca, Cambridge, UK, 19.Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland, 20.David Geffen School of Medicine at UCLA, Los Angeles, CA, USA, 21.Chinese University of Hong Kong, Hong Kong, China)

^○Takayasu Kurata¹, James Chih-Hsin Yang², Isamu Okamoto³, Li Zhang⁴, Jie Hu⁵, Donglin Wang⁶, Chengping Hu⁷, Jianying Zhou⁸, Lin Wu⁹, Lejie Cao¹⁰, Jiwei Liu¹¹, Helong Zhang¹², Hong Sun¹³, Ziping Wang¹⁴, Hongjun Gao¹⁵, Yan Yan¹⁶, Suijun Xiao¹⁶, Jianxin Lin¹⁷, M. Catherine Pietanza¹⁷, Ying Cheng¹⁸ (1.Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan, 2.Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Republic of China, 3.Kyushu University Hospital, Fukuoka, Japan, 4.Respiratory Medicine Department, Peking Union Medical College Hospital, Beijing, China, 5.Department of Pulmonary Medicine, Zhongshan Hospital Fudan University, Shanghai, China, 6.Department of Oncology, Chongqing Cancer Hospital, Chongqing, China, 7.Department of Respirology and Critical Care Medicine, Xiangya Hospital Central South University, Changsha, China, 8.Department of Respiratory Diseases, The First Affiliated Hospital of Zhejiang University, Hangzhou, China, 9.Department of Thoracic Medicine, Hunan Cancer Hospital, Changsha, China, 10.Department of Respiration, The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei, China, 11.Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, China, 12.Department of Oncology, Tang Du Hospital, The Fourth Military Medical University, Xi'an, China, 13.Department of Oncology, The First Affiliated Hospital of Xi’An Jiaotong University, Xi'an, China, 14.Department of Thoracic Medical Oncology, Beijing Cancer Hospital, Beijing, China, 15.Department of Pulmonary Oncology, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China, 16.MSD, Shanghai, China, 17.Merck & Co., Inc., Kenilworth, NJ, USA, 18.Department of Medical Oncology, Jilin Cancer Hospital, Chaoyang Borough, Changchun, China)

^○Kaoru Kubota¹, Byoung Chul Cho², Vichien Srimuninnimit³, Yu Fan⁴, Jianying Zhou⁵, Li Zhang⁶, Qing Zhou^7,8, Yukio Hosomi⁹, Hiroaki Takeoka¹⁰, Rinee Mukherjee¹¹, Wei Fu¹¹, Fabricio Souza¹¹, Tony S. K. Mok¹², Li Zhang¹³ (1.Department of Pulmonary Medicine and Oncology, Nippon Medical School Hospital, Tokyo, Japan, 2.Division of Medical Oncology, Yonsei Cancer Center, Seoul, South Korea, 3.Department of Medicine, Siriraj Hospital, Bangkok, Thailand, 4.Thoracic Medical Oncology Department of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China, 5.Department of Respiratory Diseases, The First Affiliated Hospital of Zhejiang University, Hangzhou, China, 6.Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China, 7.Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Lung Cancer Institute, Guangzhou, China, 8.Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China, 9.Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan, 10.Department of Respiratory Medicine, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan, 11.Merck & Co., Inc., Kenilworth, NJ, USA, 12.Clinical Oncology, State Key Laboratory of Translational Oncology, Chinese University of Hong Kong, Shatin, Hong Kong, China, 13.Peking Union Medical College Hospital, Beijing, China)

^○Nobukazu Fujimoto¹, Solange Peters², Arnaud Scherpereel³, Robin Cornelissen⁴, Youssef Oulkhouir⁵, Laurent Greillier⁶, Muhammet Ali Kaplan⁷, Toby Talbot⁸, Isabelle Monnet⁹, Sandrine Hiret¹⁰, Paul Baas¹¹, Anna K. Nowak¹², Anne S. Tsao¹³, Aaron S. Mansfield¹⁴, Sanjay Popat¹⁵, Xiaoqing Zhang¹⁶, Nan Hu¹⁶, David Balli¹⁶, Jenine Sanzari¹⁶, Gerard Zalcman¹⁷ (1.Department of Medical Oncology, Okayama Rosai Hospital, 2.Lausanne University Hospital, Lausanne, Switzerland, 3.University of Lille, CHU Lille, INSERM, OncoThAI, Lille, France, 4.Erasmus MC Cancer Institute, Rotterdam, Netherlands, 5.Hôpital Côte de Nacre CHU Caen, Caen, France, 6.Aix Marseille University, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Marseille, France, 7.Dicle University, Diyarbakir, Turkey, 8.Royal Cornwall Hospitals NHS Trust, Truro, UK, 9.Centre Hospitalier Intercommunal de Creteil, Créteil, France, 10.Institut de Cancérologie de l'Ouest, Saint-Herblain Cedex, France, 11.Netherlands Cancer Institute and Leiden University Medical Center, Amsterdam, Netherlands, 12.University of Western Australia and Sir Charles Gairdner Hospital, Perth, Australia, 13.MD Anderson Cancer Center, Houston, TX, USA, 14.Mayo Clinic, Rochester, MN, USA, 15.Royal Marsden Hospital and Institute of Cancer Research, London, UK, 16.Bristol Myers Squibb, Princeton, NJ, USA, 17.Bichat-Claude Bernard University Hospital, AP-HP, Université de Paris, Paris, France)

^○Takashi Kijima¹, Terufumi Kato², Yasushi Goto³, Takashi Yokoi¹, Kozo Kuribayashi¹, Koji Mikami¹, Yasuko Fuchimoto⁴, Shuji Murakami², Tatsuya Yoshida³, Masae Homma⁵, Akira Wakana⁵, Kazuo Noguchi⁵, Nobukazu Fujimoto⁶ (1.Department of Respiratory Medicine and Hematology, Hyogo College of Medicine, 2.Department of Thoracic Oncology, Kanagawa Cancer Center, 3.Department of Thoracic Oncology, National Cancer Center Hospital, 4.Department of Respiratory Medicine, Okayama Rosai Hospital, 5.MSD K.K., Tokyo, Japan, 6.Department of Medical Oncology, Okayama Rosai Hospital)